Navigation Links
The Myxo File Part III, Biographical story of a Cardiologist requesting help from the President, Barack H. Obama, for her patients in Chicago

CHICAGO, Jan. 29, 2013 /PRNewswire/ --The Myxo File: Part III, Published January 24, 2013, just released through Kindle Direct Publishing, will provide documents from the FDA, SEC and the U.S. patent office action to further understand the issues that go into heart device manufacturing and safety issues in U.S. patients. A providential meeting with the President of the United States on his birthday in Chicago, with the author and her mother, will turn the events for the patients going to open-heart surgery in the U.S.A. forever.

(Photo: )

"The patients need to understand this process and the Myxo File Part III provides a step-by-step chart for a patient to ask the important questions prior to going for open heart surgery,"  says author Nalini Marie Rajamannan M.D. of Sacred Heart Cardiology, Chicago IL.

"My book will help to educate the citizens of the United States of America and globally to ask the important questions prior to open heart surgery as to whether the device that will be used to repair their valve is FDA registered, cleared, approved, investigational or none of the above," says Dr. Rajamannan.

Rajamannan was inspired to create the Myxo File when the documents she accumulated over a five-year quest to get the information regarding the patients ended with a search of the U.S. SEC website. The filings indicate the chronology of disclosures of the medical device to investors. "With my electronic file and 3-Agency Chart, you still have to take action, and ask your physicians whether you are about to be included in a clinical study to test devices prior to FDA clearance, but at least the citizens of the United States will have a guidepost to help them ask the right questions.

Nalini M. Rajamannan is a cardiologist at Sacred Heart Cardiology, Sheboygan, WI, and Chicago, IL. She is the CEO of ConcieValve LLC, and recently published her textbook on Cardiac Valvular Medicine, Springer Publisher. She graduated from the University of Notre Dame, South Bend IN and Mayo Medical School and Mayo Graduate School, Rochester MN for all of her medical training. She is the chair of the recently published position statement from the NHLBI, NIH working group on Calcific Aortic Valve Disease. Dr. Rajamannan has published an International Clinical trial on the effects of statins in slowing the progression of aortic valve disease in the Journal of the American College of Cardiology with her colleagues from Spain and Portugal.

SOURCE Nalini Rajamannan, MD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Arthritis Associates of South Florida Acquires Access to Patient Health History Faster with Digital Pen Technology from Anoto and NextGen Healthcare
2. Medical Marijuana Inc.s Subsidiary, PhytoSPHERE Systems, Signs the Largest Production Contract in Company History Valued at $7.5 Million
3. Shield HealthCare Announces 12th Annual Caregiver Story Contest
4. Producer Austin Chapman Reaches Millions with Inspiring Story on Hearing Loss; Launches Contest in Partnership with Phonak
5. Star Scientific, Inc. Refutes Story Published on
6. Arbor Pharmaceuticals partners with the Association of Black Cardiologists to further the campaign of "Saving Hearts of a Diverse America"
7. Top New York City Cardiologist Dr. Steven Reisman to be Featured on Inside Edition to Discuss Mini-Strokes and Strokes
8. Leading Cardiologist Dispels the Myths about Dietary Supplement Niacin
9. Watson Names Lisa DeFrancesco Vice President, Global Investor Relations
10. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
11. Merz, Inc. Announces Promotion of Katrina Church to Vice President, Chief Compliance Officer
Post Your Comments:
(Date:10/12/2015)... Given the intricacy of the anatomy and physiology of ... drug effectively to a specific ocular site. Several barriers have ... include dilution of a drug by tears, clearance of a ... issues with respect to the cornea, sclera and choroid. Approximately ... due to the aforementioned barriers. --> Given ...
(Date:10/12/2015)... 12, 2015  Former White House Spokesman, and Drug Czar ... House Narcotics Committee, Robert Weiner , and Policy Analyst ... two emphasize that this is now a potential bipartisan campaign ... Jeb Bush , Carly Fiorina to Rand ... federal statistics, which they call "a shocker: 23 million need ...
(Date:10/12/2015)... 2015  Luminex Corporation (NASDAQ: LMNX ) today announced ... ended September 30, 2015 on Monday, November 2, 2015. A ... the close of trading. --> ... discuss the operating highlights and financial results for the third ... 4:30 p.m. Eastern time. . Simply ...
Breaking Medicine Technology:
(Date:10/13/2015)... CA (PRWEB) , ... October 13, 2015 , ... According ... Care, a recent study has shown that women who successfully lose weight with a ... in the United States each year. The article notes that anywhere from 40 to ...
(Date:10/13/2015)... ... 13, 2015 , ... Altec Products, Inc., the leader in ... Dynamics AXUG, GPUG and NAVUG Summits to take place the week of October ... user conferences designed and led by users to provide attendees with a unique ...
(Date:10/13/2015)... ... 13, 2015 , ... Element Blue ™, a leading ... company, RightSensor™ LLC, an Internet of Things (IoT) hardware supplier that delivers custom ... approach for customers requiring sensor hardware for critical data environments. , RightSensor™, working ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... private messaging application, announced today a significant contract that will provide its award-winning ... plans to build on the growing success of its Relay program, IBX Wire™, ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... e-con Systems ... solutions, today announced See3CAM_CU40, the industry’s first RGB-IR pixel format camera with ... a new member of e-con’s See3CAM family of UVC USB 3.0 cameras, is based ...
Breaking Medicine News(10 mins):